PharmaCann Inc. will completely shut its hashish cultivation and processing facility close to Olyphant, Pa., shedding 60 employees on Could 20 after the privately held multistate operator defaulted on its lease.
The corporate filed a Employee Adjustment and Retraining Notification (WARN) with the Pennsylvania Division of Labor and Trade on March 20, informing the division of its facility closure at 111 Life Science Drive in Scott Township.
Based in 2014, PharmaCann bought the 18 acres of land in Lackawanna County – within the Northeast area of the commonwealth – in late 2018, with plans to assemble a 36,000-square-foot facility to serve Pennsylvania’s up-and-coming medical hashish market that had commenced gross sales earlier that yr.
On the time, Higher Scranton Chamber of Commerce President Bob Durkin stated PharmaCann was among the many companies “on the reducing fringe of their respective fields” that aligned with Scott Know-how Park’s long-standing focus within the industrial zoning space.
To Learn The Relaxation Of This Article On Hashish Enterprise Instances, Click on Right here
The publish PharmaCann Closing Pennsylvania Hashish Facility, Laying Off 60 Extra Staff appeared first on Marijuana Retail Report – Information and Data for Hashish Retailers.
